GLP-1 drugs should not be used while breastfeeding 36
When cortisol rhythms normalize and SCFAs increase, appetite becomes more stable, and reward-driven cravings diminish
Key benefits including neurologic benefits, neuroplasticity, as well as a reduction in neuroinflammation, myth busting and false narratives specific to the use of these drugs, including concerns over dosing relevant to gastroparesis, too fast to titration, monotherapy, lack of strength training, gallbladder issues and so much more
Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension
Our clients are assured of having experienced lawyers and paralegals available to answer questions and solve problems